Florentia Kaguelidou

9.1k total citations · 2 hit papers
80 papers, 2.0k citations indexed

About

Florentia Kaguelidou is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Florentia Kaguelidou has authored 80 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pediatrics, Perinatology and Child Health, 17 papers in Epidemiology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Florentia Kaguelidou's work include Pharmaceutical studies and practices (23 papers), Neonatal and Maternal Infections (10 papers) and Pneumonia and Respiratory Infections (8 papers). Florentia Kaguelidou is often cited by papers focused on Pharmaceutical studies and practices (23 papers), Neonatal and Maternal Infections (10 papers) and Pneumonia and Respiratory Infections (8 papers). Florentia Kaguelidou collaborates with scholars based in France, Italy and United States. Florentia Kaguelidou's co-authors include Évelyne Jacqz-Aigrain, Juliane Léger, Corinne Alberti, Paolo Manzoni, Jean‐Claude Carel, P. Brian Smith, Daniel K. Benjamin, Reese H. Clark, Kevin Watt and Michael Cohen-Wolkowiez and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Florentia Kaguelidou

77 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units

2012 389 citations Paolo Manzoni, Évelyne Jacqz-Aigrain et al. Early Human Development profile →
Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France

2022 82 citations Corinne Lévy, Stéphane Béchet et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Florentia Kaguelidou France	21	591	516	493	468	307	80	2.0k
Veronika Northrup United States	23	282 0.5×	481 0.9×	419 0.8×	472 1.0×	338 1.1×	38	1.9k
Giacomo D. Simonetti Switzerland	26	547 0.9×	232 0.4×	170 0.3×	289 0.6×	348 1.1×	113	2.1k
G. Vidal-Trécan France	22	156 0.3×	471 0.9×	235 0.5×	254 0.5×	158 0.5×	68	1.5k
Alicia M. Neu United States	30	638 1.1×	295 0.6×	87 0.2×	468 1.0×	318 1.0×	116	3.0k
Leonard G. Feld United States	20	480 0.8×	193 0.4×	312 0.6×	139 0.3×	365 1.2×	65	2.0k
Johan Rosman Australia	30	170 0.3×	263 0.5×	327 0.7×	137 0.3×	372 1.2×	69	2.7k
David W. Mudge Australia	27	190 0.3×	225 0.4×	125 0.3×	198 0.4×	292 1.0×	76	2.0k
Tom Blydt‐Hansen Canada	27	388 0.7×	471 0.9×	130 0.3×	566 1.2×	245 0.8×	116	3.6k
Raanan Shamir Israel	12	454 0.8×	649 1.3×	111 0.2×	240 0.5×	605 2.0×	24	2.6k
Johannes P. van Hooff Netherlands	37	492 0.8×	287 0.6×	182 0.4×	415 0.9×	273 0.9×	60	2.9k

Countries citing papers authored by Florentia Kaguelidou

Since Specialization

Citations

This map shows the geographic impact of Florentia Kaguelidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florentia Kaguelidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florentia Kaguelidou more than expected).

Fields of papers citing papers by Florentia Kaguelidou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florentia Kaguelidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florentia Kaguelidou. The network helps show where Florentia Kaguelidou may publish in the future.

Co-authorship network of co-authors of Florentia Kaguelidou

This figure shows the co-authorship network connecting the top 25 collaborators of Florentia Kaguelidou. A scholar is included among the top collaborators of Florentia Kaguelidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florentia Kaguelidou. Florentia Kaguelidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lévy, Corinne, André Birgy, Stéphane Béchet, et al.. (2025). Impact of RSV Immunization on the Rate of Pediatric Acute Otitis Media: A Time-series Analysis. Clinical Infectious Diseases. 2 indexed citations

Lanoy, Émilie, et al.. (2025). Evaluation of Methods for Joinpoint Analysis of Time Series Using Simulated and Real-World Data. Journal of Clinical Epidemiology. 187. 111966–111966.

Beeker, Nathanaël, et al.. (2024). Prenatal Exposure to Proton Pump Inhibitors and Risk of Serious Infections in Offspring During the First Year of Life: A Nationwide Cohort Study. Drug Safety. 48(3). 265–277. 2 indexed citations

Felix, A., Zein Assad, Philippe Bidet, et al.. (2024). Common Seasonal Pathogens and Epidemiology of Henoch-Schönlein Purpura Among Children. JAMA Network Open. 7(4). e245362–e245362. 8 indexed citations

Beeker, Nathanaël, et al.. (2024). In Utero Exposure to Antibiotics and Risk of Serious Infections in the First Year of Life. Drug Safety. 47(5). 453–464. 2 indexed citations

Ayme‐Dietrich, Estelle, Florentia Kaguelidou, Gilles Bertschy, & Laurent Chouchana. (2024). Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults. Pharmacoepidemiology and Drug Safety. 33(6).

Acquaviva, Éric, Naïm Ouldali, Aurélie Bourmaud, et al.. (2024). Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic. JAMA Network Open. 7(4). e247965–e247965. 11 indexed citations

Assad, Zein, Naïm Ouldali, E. Bui Quoc, et al.. (2023). Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis. The Journal of Pediatrics. 263. 113682–113682. 4 indexed citations

Bushnell, Greta, Susan dosReis, Wendy Camelo Castillo, et al.. (2023). Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 Pandemic. Psychiatric Services. 74(8). 880–884. 2 indexed citations

10.

Trinh, Nhung TH, et al.. (2022). Pediatric Prescriptions of Proton Pump Inhibitors in France (2009-2019): A Time-Series Analysis of Trends and Practice Guidelines Impact. The Journal of Pediatrics. 245. 158–164.e4. 21 indexed citations

11.

Banaschewski, Tobias, Laurent Chouchana, Simon Day, et al.. (2021). c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper. British Journal of Clinical Pharmacology. 88(12). 4997–5016. 7 indexed citations

12.

Kaguelidou, Florentia, Énora Le Roux, Laura Mangiarini, et al.. (2019). Non-inferiority double-blind randomised controlled trial comparing gabapentin versus tramadol for the treatment of chronic neuropathic or mixed pain in children and adolescents: the GABA-1 trial—a study protocol. BMJ Open. 9(2). e023296–e023296. 9 indexed citations

13.

Élie, Valery, Stéphanie Leroux, Florentia Kaguelidou, & Évelyne Jacqz-Aigrain. (2018). Drug evaluation in children 10 years after the European pediatric regulation current challenges and perspectives. Therapies. 73(2). 113–117. 6 indexed citations

14.

Koehl, Bérengère, Wei Zhao, Florentia Kaguelidou, et al.. (2017). Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease. Blood. 130(Suppl_1). 975–975. 5 indexed citations

15.

Ferrajolo, Carmen, Caitlin Dodd, Alexandra Păcurariu, et al.. (2016). Pharmacoepidemiological safety studies in children: a systematic review. Pharmacoepidemiology and Drug Safety. 25(8). 861–870. 18 indexed citations

16.

Fregonese, Federica, Carmen Ferrajolo, Katia Verhamme, et al.. (2015). Pediatric Drug Safety Signal Detection: A New Drug–Event Reference Set for Performance Testing of Data-Mining Methods and Systems. Drug Safety. 38(2). 207–217. 19 indexed citations

17.

Jacqz-Aigrain, Évelyne, Éric Konofal, Wei Zhao, et al.. (2014). Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder. Drug Design Development and Therapy. 8. 2321–2321. 14 indexed citations

18.

Manzoni, Paolo, Stefano Rizzollo, Caterina Carbonara, et al.. (2012). Neonatal cutaneous disseminated aspergillosis in a preterm extremely-low-birth-weight infant with favourable outcome at 3-year follow-up: a case report. Early Human Development. 88. S65–S68. 7 indexed citations

19.

Léger, Juliane, et al.. (2011). Positive Impact of Long-Term Antithyroid Drug Treatment on the Outcome of Children with Graves' Disease: National Long-Term Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 97(1). 110–119. 105 indexed citations

20.

Beltrand, Jacques, Florentia Kaguelidou, Rasa Verkauskienė, et al.. (2009). Catch-Up Growth Following Fetal Growth Restriction Promotes Rapid Restoration of Fat Mass but Without Metabolic Consequences at One Year of Age. PLoS ONE. 4(4). e5343–e5343. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact